Georg Loss

Georg Loss

Auto-generated profile, based on publicly available information

Georg Loss

F. Hoffmann-La Roche Ltd, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PKPirkka V. Kirjavainen
Pirkka V. Kirjavainen
AKAnne M. Karvonen
Anne M. Karvonen
RARachel I. Adams
Rachel I. Adams
Martin TäubelMartin Täubel
Martin Täubel
MRMarjut Roponen
Marjut Roponen
JPJuha Pekkanen
Juha Pekkanen

1 April 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
CRCaroline Roduit
Caroline Roduit
RFRemo Frei
Remo Frei
MDMartin Depner
Martin Depner
BSBianca Schaub
Bianca Schaub
GLGeorg Loss
Georg Loss
RLRoger Lauener
Roger Lauener

1 October 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
GLGeorg Loss
Georg Loss
SASilvia Apprich
Silvia Apprich
MWMarco Waser
Marco Waser
WKWolfgang Kneifel
Wolfgang Kneifel
JGJon Genuneit
Jon Genuneit
CBCharlotte Braun-Fahrländer
Charlotte Braun-Fahrländer

1 June 2012 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
SISabina Illi
Sabina Illi
MDMartin Depner
Martin Depner
JGJon Genuneit
Jon Genuneit
EHElisabeth Horak
Elisabeth Horak
GLGeorg Loss
Georg Loss
EMErika von Mutius
Erika von Mutius

1 February 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
ALAnna Lluis
Anna Lluis
MDMartin Depner
Martin Depner
BGBeatrice Gaugler
Beatrice Gaugler
PSPhilippe Saas
Philippe Saas
VCVera Isabel Casaca
Vera Isabel Casaca
GDG. Doekes
G. Doekes

15 April 2016 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
GLGeorg J. Loss
Georg J. Loss
MDMartin Depner
Martin Depner
AHAlexander J. Hose
Alexander J. Hose
JGJon Genuneit
Jon Genuneit
AKAnne M. Karvonen
Anne M. Karvonen
MEMe Ee
Me Ee
Rationale: Growing up on a farm protects from childhood asthma and early wheeze. Virus-triggered wheeze in infancy predicts asthma in individuals with a genetic asthma risk associated with chromosome 17q21. Objectives: To test environmental determinants of infections and wheeze in the first year of life, potential modifications of these associations by 17q21, and the implications for different trajectories of wheeze. Methods: We followed 983 children in rural areas of Europe from birth until age 6 years. Symptoms of wheeze, rhinitis, fever, and environmental exposures were documented with weekly diaries during year 1. Asthma at age 6 was defined as ever having a reported doctor’s diagnosis. Single-nucleotide polymorphisms related to ORMDL3 (rs8076131) and GSDMB (rs7216389, rs2290400) at 17q21 were genotyped. Measurements and Main Results: Early wheeze was positively associated with presence of older siblings among carriers of known asthma risk alleles at 17q21 (e.g., rs8076131) (adjusted odds ratio [aOR], 1.53; 95% confidence interval [CI], 1.16–2.01). Exposure to farm animal sheds was inversely related to wheeze (aOR, 0.44; 95% CI, 0.33–0.60). Both effects were similarly observed in children with transient wheeze up to age 3 years without subsequent development of asthma (aOR, 1.71 [95% CI, 1.09–2.67]; and aOR, 0.48 [95% CI, 0.30–0.76], respectively). Conclusions: These findings suggest that the chromosome 17q21 locus relates to episodes of acute airway obstruction common to both transient wheeze and asthma. The previously identified asthma risk alleles are the ones susceptible to environmental influences. Thus, this gene–environment interaction reveals two faces of 17q21: The same genotype constitutes genetic risk and allows for environmental protection, thereby providing options for prospective prevention strategies.